Category - Pharma Industry News
UK government allocates up to £680m a year to two funds offering cutting-edge treatments
FDA approves GSK’s Priorix vaccine for measles, mumps and rubella
Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis
Almirall shares positive topline results from atopic dermatitis trials
Pfizer to expand Paxlovid manufacturing in US to meet global demand
Bachem and Eli Lilly link up to advance oligonucleotide products
Vertex trial for hypoglycaemia therapy shows early promise
Daiichi Sankyo and AstraZeneca’s Enhertu delivers promising trial results